Cargando…
Health-related Quality of Life in Hormone Receptor-Positive Early Breast Cancer: Analyses From the Surveillance, Epidemiology, and End Results Medicare Health Outcomes Survey
This study describes health-related quality of life (HRQoL) among older Medicare beneficiaries with hormone receptor-positive (HR+) early breast cancer (eBC). Women aged ≥65 years diagnosed with stage I-III HR+ eBC between 1997 and 2014 using the Surveillance, Epidemiology, and End Results Medicare...
Autores principales: | Nabulsi, Nadia A, Naing, Khatija W, Deng, Huiwen, Cueto, Jenilee, Asfaw, Alemseged A, Hubbard, Colin C, Zhou, Jifang, Lee, Inyoung, Mitra, Debanjali, Calip, Gregory S, Law, Ernest H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277434/ https://www.ncbi.nlm.nih.gov/pubmed/35846244 http://dx.doi.org/10.1177/23743735221113058 |
Ejemplares similares
-
Impact of time to distant recurrence on breast cancer-specific mortality in hormone receptor-positive breast cancer
por: Calip, Gregory S., et al.
Publicado: (2022) -
Population-based recurrence rates among older women with HR-positive, HER2-negative early breast cancer: Clinical risk factors, frailty status, and differences by race
por: Zhou, Jifang, et al.
Publicado: (2021) -
Sociodemographic and Psychological Risk Factors for Anxiety and Depression: Findings from the Covid-19 Health and Adherence Research in Scotland on Mental Health (CHARIS-MH) Cross-sectional Survey
por: Hubbard, Gill, et al.
Publicado: (2021) -
Reversal of Oral Anticoagulants: A Survey of Contemporary Practice Trends (ReACT)
por: Deng, Huiwen, et al.
Publicado: (2023) -
Risk of recurrence among patients with HR-positive, HER2-negative, early breast cancer receiving adjuvant endocrine therapy: A systematic review and meta-analysis
por: Salvo, Elizabeth M., et al.
Publicado: (2021)